相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。NK cell-based cancer immunotherapy: from basic biology to clinical development
Sizhe Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells
Hila Shaim et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma
H. J. Close et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes
Ekaterina Friebel et al.
CELL (2020)
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
Florian Klemm et al.
CELL (2020)
The Role of Selected Chemokines and Their Receptors in the Development of Gliomas
Magdalena Groblewska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
Florent Petitprez et al.
FRONTIERS IN IMMUNOLOGY (2020)
Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma
Weilun Fu et al.
FRONTIERS IN IMMUNOLOGY (2020)
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma The CheckMate 143 Phase 3 Randomized Clinical Trial
David A. Reardon et al.
JAMA ONCOLOGY (2020)
Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy
Eliane Klein et al.
FRONTIERS IN ONCOLOGY (2020)
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy et al.
NATURE MEDICINE (2019)
Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro
Yoshitaka Tanaka et al.
PLOS ONE (2019)
Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
Weilei Hu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Vascular regulation of antitumor immunity
Lance L. Munn et al.
SCIENCE (2019)
A 3D tumor spheroid model for the T98G Glioblastoma cell line phenotypic characterization
Mariam-Eleni Oraiopoulou et al.
TISSUE & CELL (2019)
被撤回的出版物: CXCL8 Promotes Glioma Progression By Activating The JAK/STAT1/HIF-1 alpha/Snail Signaling Axis (Retracted article. See vol. 16, pg. 211, 2023)
Zhiming Chen et al.
ONCOTARGETS AND THERAPY (2019)
Tumor immunotherapy: New aspects of natural killer cells
Yangxi Li et al.
CHINESE JOURNAL OF CANCER RESEARCH (2018)
Molecular insight into targeting the NK cell immune response to cancer
Jai Rautela et al.
IMMUNOLOGY AND CELL BIOLOGY (2018)
CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma
Kartik Angara et al.
NEOPLASIA (2018)
GlioVis data portal for visualization and analysis of brain tumor expression datasets
Robert L. Bowman et al.
NEURO-ONCOLOGY (2017)
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller et al.
LANCET ONCOLOGY (2017)
Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane
Ravi Kumar et al.
PLOS ONE (2017)
The Microenvironmental Landscape of Brain Tumors
Daniela F. Quail et al.
CANCER CELL (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
3D tumor spheroids: an overview on the tools and techniques used for their analysis
Elisabete C. Costa et al.
BIOTECHNOLOGY ADVANCES (2016)
Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity
Christine Pasero et al.
CANCER RESEARCH (2016)
MicroRNA-29b mediates altered innate immune development in acute leukemia
Bethany L. Mundy-Bosse et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages
Teresa E. Peterson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Pathophysiological mechanisms regulated by cytokines in gliomas
Anthos Christofides et al.
CYTOKINE (2015)
Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer
Naoyuki Sakamoto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Spherical Cancer Models in Tumor Biology
Louis-Bastien Weiswald et al.
NEOPLASIA (2015)
Effect of tumor cells and tumor microenvironment on NK-cell function
Massimo Vitale et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Proteomic Comparison of 3D and 2D Glioma Models Reveals Increased HLA-E Expression in 3D Models is Associated with Resistance to NK Cell-Mediated Cytotoxicity
Weiqi He et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Sema3C Promotes the Survival and Tumorigenicity of Glioma Stem Cells through Rac1 Activation
Jianghong Man et al.
CELL REPORTS (2014)
U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells
Anja Torsvik et al.
CANCER MEDICINE (2014)
3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing
Paola Longati et al.
BMC CANCER (2013)
Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
Lin Cheng et al.
CELL (2013)
Microglia and Macrophages in Malignant Gliomas: Recent Discoveries and Implications for Promising Therapies
Anna Carolina Carvalho da Fonseca et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Molecular Pathways: Coexpression of Immune Checkpoint Molecules: Signaling Pathways and Implications for Cancer Immunotherapy
Christopher J. Nirschl et al.
CLINICAL CANCER RESEARCH (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Patient-Specific Orthotopic Glioblastoma Xenograft Models Recapitulate the Histopathology and Biology of Human Glioblastomas In Situ
Kyeung Min Joo et al.
CELL REPORTS (2013)
Glioblastoma cell line-derived spheres in serum-containing medium versus serum-free medium: A comparison of cancer stem cell properties
Xin Hong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
Kate Lawrenson et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Cancer Stem Cells in Gliomas: Identifying and Understanding the Apex Cell in Cancer's Hierarchy
Monica Venere et al.
GLIA (2011)
The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling
Yi-fang Ping et al.
JOURNAL OF PATHOLOGY (2011)
NOTCH Pathway Blockade Depletes CD133-Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts
Xing Fan et al.
STEM CELLS (2010)
U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line
Michael James Clark et al.
PLOS GENETICS (2010)
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
Nicholas D. Huntington et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Spheroid-based drug screen: considerations and practical approach
Juergen Friedrich et al.
NATURE PROTOCOLS (2009)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
Direct orthotopic transplantation of fresh surgical specimen preserves CD133(+) tumor cells in clinically relevant mouse models of medulloblastoma and glioma
Qin Shu et al.
STEM CELLS (2008)
The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids
P. C. De Witt Hamer et al.
ONCOGENE (2008)
Protein kinase C regulates expression and function of inhibitory killer cell ig-like receptors in NK cells
Diana A. Alvarez-Arias et al.
JOURNAL OF IMMUNOLOGY (2007)
Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1
Nicholas D. Huntington et al.
NATURE IMMUNOLOGY (2007)
CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers
Bo Huang et al.
CANCER LETTERS (2007)
Tumor growth impedes natural-killer-cell maturation in the bone marrow
John O. Richards et al.
BLOOD (2006)
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
YT Bryceson et al.
BLOOD (2006)
Natural-killer cells and dendritic cells: l' union fait la force
T Walzer et al.
BLOOD (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Analysis of high density expression microarrays with signed-rank call algorithms
WM Liu et al.
BIOINFORMATICS (2002)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
The development of necrosis and apoptosis in glioma: experimental findings using spheroid culture systems
HS Bell et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2001)
分享论文
